Physician profile
Warren Conway
NPI 1245290717
$12,333.62
in general payments reported to CMS, 2019-2025
44 companies · $838 in 2025
The $838 reported for 2025 was more than what 83% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,129 · 2020: $1,543 · 2021: $1,631 · 2022: $1,247 · 2023: $5,006 · 2024: $939 · 2025: $838.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,631 · Travel and Lodging: $3,153.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,630.60 |
| Travel and Lodging | $3,152.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Modernatx, INC. | $3,829.62 | 2023 | |
| Novo Nordisk INC | $2,008.34 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $1,288.61 | 2020-2025 | Vraylar, Ubrelvy, Qulipta |
| Astrazeneca Pharmaceuticals Lp | $828.28 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Lilly USA, LLC | $446.78 | 2019-2025 | Mounjaro, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $399.44 | 2019-2025 | Jardiance |
| Takeda Pharmaceuticals U.S.A., INC. | $372.87 | 2019-2022 | |
| Allergan, INC. | $332.54 | 2019-2020 | |
| Pfizer INC. | $316.15 | 2019-2025 | |
| Amgen INC. | $302.35 | 2019-2024 | Evenity, Prolia |
| Exact Sciences Corporation | $256.80 | 2023-2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $229.44 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $186.07 | 2019-2023 | |
| Glaxosmithkline, LLC. | $185.48 | 2019-2024 | Arexvy, Trelegy Ellipta, Shingrix |
| Amarin Pharma, INC. | $153.16 | 2019-2022 |
Show all 41 companies
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Warren Conway listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.